MG
MEDP icon

Mather Group’s Medpace MEDP Stock Holding History

Mather Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9K Hold
30
– – ﹤0.01% 1387
2026
Q1 		$14.4K Buy
+30
New +$15.4K ﹤0.01% 1361
2025
Q4 		– Sell
-43
Closed -$22.1K – 1255
2025
Q3 		$22.1K Buy
+43
New +$18.8K ﹤0.01% 1098
2025
Q2 		– Sell
-46
Closed -$14K – 1283
2025
Q1 		$14K Buy
46
+16
+53% +$5.38K ﹤0.01% 1176
2024
Q4 		$9.97K Hold
30
– – ﹤0.01% 1249
2024
Q3 		$10K Sell
30
-18
-38% -$6.84K ﹤0.01% 1183
2024
Q2 		$19.4K Sell
48
-21
-30% -$8.32K ﹤0.01% 1269
2024
Q1 		$21.2K Buy
+69
New +$24.3K ﹤0.01% 1050

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Mather Group's MEDP Position: Q2 2026 in Review

Mather Group held its Medpace (MEDP) position steady in Q2 2026 at 30 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Mather Group first reported a position in MEDP in Q1 2024 and has held it in 8 quarters since. The position peaked at $22.1K in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Mather Group held 30 shares of Medpace worth $15.9K as of Q2 2026.
  • Mather Group left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1387 holding.
  • Mather Group first reported a position in Medpace in Q1 2024 and has held it in 8 quarters since.
  • Mather Group's Medpace position peaked at $22.1K in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.